• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Betacalcip Teva
    / Teva


    Active Ingredient *

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tube

    30 g, 60 g, 120 g

    full basket chart

    Dosage

    should be applied to the affected area once daily.
    The recommended treatment period is 4 weeks. Treatment should be continued after medical review and under regular medical supervision.
    When using calcipotriol containing medicinal products, the maximum daily dose should not exceed 15 g. The body surface area treated with calcipotriol containing medicinal products should not exceed 30% .


    Indications

    Topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy


    Contra-Indications

    Hypersensitivity to the active substances or to any of the excipients.
    This ointment is contraindicated in erythrodermic, exfoliative and pustular psoriasis.
    Due to the content of calcipotriol, this ointment is contraindicated in patients with known disorders of calcium metabolism .
    Due to the content of corticosteroid, this ointment is contraindicated in the following conditions: Viral (e.g. herpes or varicella) lesions of the skin, fungal or bacterial skin infections, parasitic infections, skin manifestations in relation to tuberculosis, perioral dermatitis, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne vulgaris, acne rosacea, rosacea, ulcers and wounds.


    Special Precautions

    Not recommended for use under 18 years of age
    Please refer to the license holder for further details.


    Side Effects

    Itching, skin peeling. Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.


    Important notes

    Please refer to the license holder for further details.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE